Gazette.govt.nzPursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:
Schedule
| Product: | 3TC |
| Active Ingredient: | Lamivudine 10mg/mL |
| Dosage Form: | Oral solution |
| New Zealand Sponsor: | GlaxoSmithKline NZ Limited |
| Manufacturer: | Bora Pharmaceutical Services Inc, Mississauga, Canada |
| Product: | 3TC |
| Active Ingredient: | Lamivudine 150mg |
| Dosage Form: | Film coated tablet |
| New Zealand Sponsor: | GlaxoSmithKline NZ Limited |
| Manufacturers: | Glaxo Operations UK Limited t/a Glaxo Wellcome Operations, Ware, United Kingdom Delpharm Poznan S.A., Poznan, Poland |
| Product: | 3TC |
| Active Ingredient: | Lamivudine 300mg |
| Dosage Form: | Film coated tablet |
| New Zealand Sponsor: | GlaxoSmithKline NZ Limited |
| Manufacturers: | Glaxo Operations UK Limited t/a Glaxo Wellcome Operations, Ware, United Kingdom Delpharm Poznan S.A., Poznan, Poland |
| Product: | Kivexa |
| Active Ingredients: | Abacavir sulphate 702mg equivalent to abacavir 600mg Lamivudine 300mg |
| Dosage Form: | Film coated tablet |
| New Zealand Sponsor: | GlaxoSmithKline NZ Limited |
| Manufacturers: | Glaxo Operations UK Limited t/a Glaxo Wellcome Operations, Ware, United Kingdom Delpharm Poznan S.A., Poznan, Poland |
| Product: | Rinvoq |
| Active Ingredient: | Upadacitinib hemihydrate 15.4mg equivalent to upadacitinib 15mg |
| Dosage Form: | Modified release tablet |
| New Zealand Sponsor: | AbbVie Limited |
| Manufacturer: | AbbVie Ireland NL B.V., Sligo, Ireland |
| Product: | Rinvoq |
| Active Ingredient: | Upadacitinib hemihydrate 30.7mg equivalent to upadacitinib 30mg |
| Dosage Form: | Modified release tablet |
| New Zealand Sponsor: | AbbVie Limited |
| Manufacturer: | AbbVie Ireland NL B.V., Sligo, Ireland |
Dated this 23rd day of June 2023.
CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).